Search

Author/Creator Povsic, Thomas J.

1. A Path Forward for Regenerative Medicine: Navigating Regulatory Challenges. Issue 4 (3rd August 2018)

Authors:
Fanaroff, Alexander C.; Morrow, Valarie; Krucoff, Mitchell W.; Seltzer, Jonathan H.; Perin, Emerson C.; Taylor, Doris A.; Miller, Leslie W.; Zeiher, Andreas M.; Fernández-Avilés, Francisco; Losordo, Douglas W.; Henry, Timothy D.; Povsic, Thomas J.
Journal:
Circulation research
Issue:
Volume 123:Issue 4(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure. (31st August 2021)

Authors:
Gilotra, Nisha A.; DeVore, Adam D.; Povsic, Thomas J.; Hays, Allison G.; Hahn, Virginia S.; Agunbiade, Tolu A.; DeLong, Allison; Satlin, Andrew; Chen, Richard; Davis, Robert; Kass, David A.
Journal:
Circulation
Issue:
Volume 14:Number 9(2021)
Page Start:
e008236
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure. (September 2021)

Authors:
Gilotra, Nisha A.; DeVore, Adam D.; Povsic, Thomas J.; Hays, Allison G.; Hahn, Virginia S.; Agunbiade, Tolu A.; DeLong, Allison; Satlin, Andrew; Chen, Richard; Davis, Robert; Kass, David A.
Journal:
Circulation
Issue:
Volume 14:Number 9(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design. Issue 2 (February 2017)

Authors:
Chakravarty, Tarun; Makkar, Raj R.; Ascheim, Deborah D.; Traverse, Jay H.; Schatz, Richard; Demaria, Anthony; Francis, Gary S.; Povsic, Thomas J.; Smith, Rachel R.; Lima, Joao A.; Pogoda, Janice M.; Marbán, Linda; Henry, Timothy D.
Journal:
Cell transplantation
Issue:
Volume 26:Issue 2(2017)
Page Start:
205
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes from the ACT34-CMI Study. Issue 9 (September 2016)

Authors:
Henry, Timothy D.; Schaer, Gary L.; Traverse, Jay H.; Povsic, Thomas J.; Davidson, Charles; Lee, Joon Sup; Costa, Marco A.; Bass, Theodore; Mendelsohn, Farrell; Fortuin, F. David; Pepine, Carl J.; Patel, Amit N.; Riedel, Norbert; Junge, Candice; Hunt, Andrea; Kereiakes, Dean J.; White, Christophe...
Journal:
Cell transplantation
Issue:
Volume 25:Issue 9(2016)
Page Start:
1701
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) study. (31st May 2017)

Authors:
Teerlink, John R.; Metra, Marco; Filippatos, Gerasimos S.; Davison, Beth A.; Bartunek, Jozef; Terzic, Andre; Gersh, Bernard J.; Povsic, Thomas J.; Henry, Timothy D.; Alexandre, Bertrand; Homsy, Christian; Edwards, Christopher; Seron, Aymeric; Wijns, William; Cotter, Gad
Journal:
European journal of heart failure
Issue:
Volume 19:Number 11(2017)
Page Start:
1520
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes. (23rd October 2020)

Authors:
Bartunek, Jozef; Terzic, Andre; Davison, Beth A.; Behfar, Atta; Sanz‐Ruiz, Ricardo; Wojakowski, Wojciech; Sherman, Warren; Heyndrickx, Guy R.; Metra, Marco; Filippatos, Gerasimos S.; Waldman, Scott A.; Teerlink, John R.; Henry, Timothy D.; Gersh, Bernard J.; Hajjar, Roger; Tendera, Michal; Senger...
Journal:
ESC heart failure
Issue:
Volume 7:Number 6(2020)
Page Start:
3345
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. CD34+ cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina. (12th June 2020)

Authors:
Johnson, Grace L.; Henry, Timothy D.; Povsic, Thomas J.; Losordo, Douglas W.; Garberich, Ross F.; Stanberry, Larissa I.; Strauss, Craig E.; Traverse, Jay H.
Journal:
Stem cells translational medicine
Issue:
Volume 9:Number 10(2020)
Page Start:
1147
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗